Clarus appoints CMO and CSO
This article was originally published in Scrip
Privately held biotech Clarus Therapeutics has hired Dr Theodore Danoff and Dr Wael Salameh as vice-president of clinical development and chief medical officer, and vice-president of medical affairs and chief scientific officer, respectively. Dr Danoff recently served as vice-president of clinical development and medical affairs at Endo Pharmaceuticals. Dr Salameh was previously on the medical faculties of Temple University and UCLA. He has also served as senior medical director and team leader for early clinical stage biomarker development at Genentech.